MX2017014020A - Terapia antimicrobiana. - Google Patents

Terapia antimicrobiana.

Info

Publication number
MX2017014020A
MX2017014020A MX2017014020A MX2017014020A MX2017014020A MX 2017014020 A MX2017014020 A MX 2017014020A MX 2017014020 A MX2017014020 A MX 2017014020A MX 2017014020 A MX2017014020 A MX 2017014020A MX 2017014020 A MX2017014020 A MX 2017014020A
Authority
MX
Mexico
Prior art keywords
hogocidin
methods
compositions
peptides
antimicrobial therapy
Prior art date
Application number
MX2017014020A
Other languages
English (en)
Inventor
Nakatsuji Teruaki
L Gallo Richard
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2017014020A publication Critical patent/MX2017014020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporcionan métodos y composiciones que comprenden péptidos de hogocidina (SH-lantibioticos), derivados y variantes. Tambien se proporcionan métodos y composiciones que comprenden composiciones probióticas que utilizan cepas de S. hominis y s. epidermis que producen hogocidina, péptidos similares a hogocidina, u otros inhibidores de patógenos de la piel. También se proporcionan métodos de tratamiento para infecciones de la piel microbiana y dermatitis atópica.
MX2017014020A 2015-05-05 2016-05-05 Terapia antimicrobiana. MX2017014020A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562157248P 2015-05-05 2015-05-05
US201662300274P 2016-02-26 2016-02-26
PCT/US2016/031067 WO2016179440A2 (en) 2015-05-05 2016-05-05 Antimicrobial therapy

Publications (1)

Publication Number Publication Date
MX2017014020A true MX2017014020A (es) 2018-08-14

Family

ID=57218441

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014020A MX2017014020A (es) 2015-05-05 2016-05-05 Terapia antimicrobiana.

Country Status (11)

Country Link
US (3) US20180289751A1 (es)
EP (1) EP3291824A4 (es)
JP (3) JP6981878B2 (es)
KR (2) KR102419616B1 (es)
CN (2) CN107735098B (es)
AU (2) AU2016256882B2 (es)
BR (1) BR112017023707B1 (es)
CA (1) CA2984890C (es)
HK (1) HK1250639A1 (es)
MX (1) MX2017014020A (es)
WO (1) WO2016179440A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2984890C (en) * 2015-05-05 2023-04-11 The Regents Of The University Of California Antimicrobial therapy
CN105796624A (zh) * 2016-05-11 2016-07-27 西安膳方医药科技有限公司 一种改善生物体表健康的方法
JP7252203B2 (ja) * 2017-08-08 2023-04-04 ユニヴェルシテ ドゥ ヴェルサイユ サン カンタン アン イヴリーヌ 人為的細菌コロニー形成を用いたスタフィロコッカス・アウレウスの防止のための医薬組成物および方法
RU2699540C2 (ru) * 2017-08-17 2019-09-06 Павел Павлович Несмиянов Композиция, содержащая пробиотические бактерии или их компоненты, и способ ее применения в лечении иммунных заболеваний кожи
AU2019203692A1 (en) * 2018-08-30 2020-03-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
MX2021003006A (es) 2018-09-13 2021-05-27 Univ California Bacterioterapia contra proprionibacterium acnes para el tratamiento de acne.
KR20210118836A (ko) * 2018-12-21 2021-10-01 매트리시스 바이오사이언스, 인크. 미생물 유래된 물질의 전달을 위한 국소 제형
JP7444362B2 (ja) 2019-02-04 2024-03-06 国立研究開発法人理化学研究所 皮膚疾患の予防、改善または治療用医薬組成物
WO2020163398A1 (en) * 2019-02-05 2020-08-13 Elanco Us Inc. Probiotic compositions comprising lactobacillus reuteri strains and methods of use
CZ308231B6 (cs) 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
EP3705131A1 (en) * 2019-03-04 2020-09-09 University College Cork-National University of Ireland, Cork Lantibiotics and lantibiotic-producing bacteria
US20220143153A1 (en) * 2019-03-08 2022-05-12 The Regents Of The University Of California Compositions and methods for treating acne
JP2021001133A (ja) * 2019-06-21 2021-01-07 ポーラ化成工業株式会社 スタフィロコッカス・ホミニス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｈｏｍｉｎｉｓ）を有効成分とする肌状態改善剤
DE102019007505A1 (de) * 2019-10-28 2021-04-29 Beiersdorf Ag Zusammensetzung mit probiotischen Bakterien und Licochalcon A
DE102019007507A1 (de) * 2019-10-28 2021-04-29 Beiersdorf Ag Zusammensetzung mit probiotischen Bakterien und Protektor-Stämmen
EP4096699A4 (en) * 2020-01-29 2024-03-13 Jackson Lab BACTERIAL ADDITIVES
WO2021154954A1 (en) * 2020-01-29 2021-08-05 Etheim Biotics, Llc Compositions and methods for treating biofilms, infections and periodontitis
US20240058395A1 (en) * 2021-01-26 2024-02-22 The Regents Of The University Of California Antimicrobial therapy
EP4082545A1 (en) 2021-04-27 2022-11-02 Diotheris Combination product and methods for preventing the emergence of antibiotic-resistant bacteria under antibiotic treatment
CN113730648B (zh) * 2021-09-06 2022-11-01 温州瑞司特生物科技有限公司 结合表皮葡萄球菌的水凝胶及其在治疗创面中的应用
CZ2021461A3 (cs) * 2021-09-30 2023-02-15 BiomServ s.r.o. Přípravky na ochranu mikrobiomu kůže a sliznic proti patogenním mikrobům a virům
WO2023086883A1 (en) * 2021-11-11 2023-05-19 Concerto Biosciences, Inc. Microbial compositions for the treatment of skin diseases
WO2023119287A1 (en) * 2021-12-22 2023-06-29 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) Nomadic bacteria and uses thereof
WO2023223993A1 (ja) * 2022-05-16 2023-11-23 マルホ株式会社 白癬治療用組成物
CN117343856A (zh) * 2022-06-28 2024-01-05 上海菌济健康科技有限公司 具有促进毛发生长的人体共生菌及其应用
EP4311537A1 (en) * 2022-07-26 2024-01-31 Beiersdorf AG Novel skin care composition for treating atopic dermatitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925556A (en) * 1996-10-02 1999-07-20 Agency Of Industrial Science And Technology Method of degrading polylactic acid resin using staphylococcus hominis and staphylococcus epidermidis
WO2007114510A1 (en) * 2006-03-31 2007-10-11 Canon Kabushiki Kaisha Probe, probe set, probe-immobilized carrier, and genetic testing method
US8148352B2 (en) * 2006-05-12 2012-04-03 The Regents Of The University Of California Antimicrobial therapy for bacterial infections
US20080026999A1 (en) * 2006-07-28 2008-01-31 Van Der Donk Wilfred A Two-component bacillus lantibiotic and methods for producing and using the same
WO2008103751A2 (en) * 2007-02-20 2008-08-28 The Regents Of The University Of California Antimicrobial and anti-inflammatory therapies and compositions
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
WO2011125015A2 (en) * 2010-04-05 2011-10-13 Bar-Ilan University Protease-activatable pore-forming polypeptides
WO2012112548A2 (en) * 2011-02-15 2012-08-23 The Regents Of The University Of California Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis
DK3035802T3 (da) * 2013-08-19 2021-10-11 Syngulon Sa Kontrolleret vækst af mikroorganismer
CA2984890C (en) * 2015-05-05 2023-04-11 The Regents Of The University Of California Antimicrobial therapy

Also Published As

Publication number Publication date
CN115715781A (zh) 2023-02-28
CN107735098A (zh) 2018-02-23
JP2023175748A (ja) 2023-12-12
JP6981878B2 (ja) 2021-12-17
EP3291824A2 (en) 2018-03-14
US20200246397A1 (en) 2020-08-06
JP2022028833A (ja) 2022-02-16
KR102624665B1 (ko) 2024-01-12
US10980848B2 (en) 2021-04-20
AU2022203288A1 (en) 2022-06-09
AU2016256882A1 (en) 2017-11-23
HK1250639A1 (zh) 2019-01-11
BR112017023707B1 (pt) 2022-03-29
CN107735098B (zh) 2022-07-29
KR20180002710A (ko) 2018-01-08
WO2016179440A3 (en) 2017-02-09
CA2984890C (en) 2023-04-11
EP3291824A4 (en) 2019-01-23
KR102419616B1 (ko) 2022-07-12
US20210228652A1 (en) 2021-07-29
BR112017023707A2 (pt) 2018-07-31
US20180289751A1 (en) 2018-10-11
WO2016179440A2 (en) 2016-11-10
CA2984890A1 (en) 2016-11-10
AU2016256882B2 (en) 2022-06-02
JP2018515488A (ja) 2018-06-14
KR20220101014A (ko) 2022-07-18
JP7348255B2 (ja) 2023-09-20

Similar Documents

Publication Publication Date Title
MX2017014020A (es) Terapia antimicrobiana.
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
PH12017501646A1 (en) Antimicrobial compounds and methods of making and using the same
HK1220624A1 (zh) 抗微生物劑的組合物和製劑、它們的方法以及用於治療微生物感染的方法
MX2016009898A (es) Tratamientos para acne resistente.
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
GB2541571A (en) Pharmaceutical compositions
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
GB2547402B (en) Prevention and treatment of microbial infections
MX2020006191A (es) Bacteriocinas terapeuticas.
ZA201908447B (en) Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections
EP3268010A4 (en) Compositions and methods for treating bacterial infection
EP3383857A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
MX2018000291A (es) Metodos para tratar la colitis.
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
ZA201907487B (en) Compositions and treatment procedures for the treatment of pathogenic infections
EP3258908A4 (en) Compositions and methods for treatment of skin infections
DK3630111T3 (en) Compounds and methods for treating bacterial infections
IN2013MU03216A (es)
EP3565551A4 (en) METHOD FOR TREATMENT OF BACTERIAL INFECTION
EP3691652A4 (en) BACTERIAL INFECTION TREATMENT PROCESSES
GB2558090B (en) Prevention and treatment for microbial infections
GB201519483D0 (en) Prevention and treatment of microbial infections